- Title
- A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
- Creators
- Luis E RAEZ - Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, P.O. Box 016960, Miami, FL 33101, United StatesKyriakos PAPADOPOULOS - Institute for Drug Development, San Antonio, TX, United StatesStewart KROLL - Threshold Pharmaceuticals, Redwood City, CA, United StatesDonald T JUNG - Threshold Pharmaceuticals, Redwood City, CA, United StatesMetin KURTOGLU - Department of Cell Biology (R-124), Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, P.O. Box 016960, Miami, FL 33101, United StatesJoseph ROSENBLATT - Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, P.O. Box 016960, Miami, FL 33101, United StatesTheodore J LAMPIDIS - Department of Cell Biology (R-124), Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, P.O. Box 016960, Miami, FL 33101, United StatesAlejandro D RICART - Institute for Drug Development, San Antonio, TX, United StatesE. Gabriella CHIOREAN - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, United StatesRobert S DIPAOLA - UMDNJ-Cancer Institute of New Jersey, New Brunswick, NJ, United StatesMark N STEIN - UMDNJ-Cancer Institute of New Jersey, New Brunswick, NJ, United StatesCaio M ROCHA LIMA - Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, P.O. Box 016960, Miami, FL 33101, United StatesJames J SCHLESSELMAN - Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, P.O. Box 016960, Miami, FL 33101, United StatesKhaled TOLBA - Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, P.O. Box 016960, Miami, FL 33101, United StatesVirginia K LANGMUIR - Threshold Pharmaceuticals, Redwood City, CA, United States
- Publication Details
- Cancer chemotherapy and pharmacology, Vol.71(2), pp.523-530
- Publisher
- Springer; Heidelberg
- Academic Unit
- Miller School of Medicine; Cell Biology Research; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 23228990
- Record Identifier
- 991031560964602976
Journal article
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Cancer chemotherapy and pharmacology, Vol.71(2), pp.523-530
2013
PMID: 23228990
Metrics
15 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
Highly Cited Paper
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis
- 1.25.1473 Warburg Effect
- Web Of Science research areas
- Oncology
- Pharmacology & Pharmacy
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites